As interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave stateside with plans for a new commercial manufacturing ...
CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (LFCR) (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today ...
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing provider, and ...
Greenwich LifeSciences updates on commercial manufacturing of GP2 and prepares for BLA filing for GLSI-100 in breast cancer treatment. Greenwich LifeSciences, Inc. announced progress in the commercial ...
GUANGZHOU, GUANGDONG, CHINA, January 19, 2026 /EINPresswire.com/ -- The rolling shutter door industry has experienced ...
Hosted on MSN
Regenxbio signals RGX-202 pivotal enrollment surpasses 50% as company initiates commercial manufacturing in Q3 2025
Curran Simpson, President and CEO, highlighted strong late-stage clinical progress and the company's positioning for multiple gene therapy launches, stating the business is “in-store for an exciting ...
NeuroSense Announces Global CDMO Selection and Manufacturing Scale-Up, Enabling Rapid Pathway to Commercialization for What is Projected to be a $100-150M Canadian Market Opportunity CAMBRIDGE, Mass., ...
Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for personalized medicine and multiproduct facilities. Automation and ...
BEND, Ore. (KTVZ) - Serán Bioscience, LLC, in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony on Thursday to celebrate the construction progress of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results